Capio announces the amendment and extension of its revolving credit facility
Capio has successfully completed an amend and extend of its MEUR 235 revolving credit facility (RCF), which is part of the total Group financing facility of MEUR 500. The agreement includes a 2.5 year extension as well as an increase of the RCF of MEUR 108.
In connection with the IPO in 2015, Capio entered into a five year multicurrency term and revolving facilities agreement of in total MEUR 500. The facility is split into a term loan facility of MEUR 265 and a revolving credit facility (RCF) of MEUR 235. On January 16, 2018, participating banks have agreed to increase the RCF by MEUR 108 to a total size of MEUR 343. The RCF was also extended to January 2023, except for MEUR 47 which will mature on the original maturity date in June 2020. All other terms have remained unchanged. The RCF is intended to be used for general corporate purposes, including acquisitions, and the extension is improving Capio’s debt maturity profile.
The agreement will not significantly impact the Group’s financial expenses in 2018.
For information, please contact:
Kristina Ekeblad, IR manager
Telephone: +46 708 31 19 40
Capio AB (publ) is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services through its hospitals, specialist clinics and primary care units. Since the Danish operation was acquired at the beginning of 2017, Capio operates in five countries; Sweden, Norway, Denmark, France and Germany. In 2016, Capio’s 12,435 employees provided healthcare services during 4.7 million patient visits across the Group’s facilities, generating net sales of MSEK 14,069. Capio operates across three geographic segments: Nordic (54% of Group net sales 2016), France (38% of Group net sales 2016) and Germany (8% of Group net sales 2016). For more information about Capio, please see www.capio.com.